Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101928370 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
WBP2NL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC00310 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RAP1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF804B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC163 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBARP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAZAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FZD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105369860 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on